About me
I am a graduate researcher specializing in antimicrobial resistance, with a focus on optimizing the global regulatory landscape for antibiotic development. My work explores clinical trial design, international approval trends, and policy frameworks that influence the introduction of novel antimicrobials. I have analyzed literature, regulatory data, and pipeline gaps to develop recommendations aimed at addressing economic and scientific challenges in AMR innovation. I am passionate about advancing equitable access to life-saving therapies and shaping evidence-based strategies to combat drug-resistant infections.
